Roles

 

 

كلية الطب البشرى                                   جامعة طرابلس

السيرة الذاتية: محمد علي ضو إغنية

 

Mohamed A Daw, MD,PhD, MPS, Pharm D, FTCDI, MRCPath(1)A ,

 

 

Professor of Clinical Microbiology and  Epidemiology , Acting Physician of Internal Medicine& infectious Diseases

 

https://www.researchgate.net/profile/Mohamed_Daw2

https://scholar.google.com.ly/citations?user=70WDUrEAAAAJ&hl=en&oi=sra

 

Faculty of Medicine,  University of Tripoli

 

 

 

E mail; mohamedadaw@gmail.com

Cellular; 00218912144972

 

 

 

Summary;

 

[ Professor Daw , is dually qualified person with both Bachelor of Medicine& surgery and Pharmaceutical sciences.  Finished his higher Education and acted  as Teaching staff at Trinity  college( A top ranked university worldwide-Ireland). He has profound teaching experience  in a top international universities including- Wales and Sarford Universities-UK,PU-Malaysia(Msc&PhD),. He is a leading expert in Clinical Microbiology, Hospital Infection, Epidemiology and Diagnostic Medicine.     He is  the founder of Libyan Journal Medicine( Medline-indiced), ranked on the top (no one) in Arab and African countries(2018- According IF-Google Scholar) . He has been nominated as  the Vice-president of EMAME- He is the first to establish, postgraduate studies in Faculty of Medicine( MSc&PhD), the Libyan National Research Centre, and Central Laboratory and created the National policy for blood supply and screening in Libyan blood banks. He helped in establishing the  credentials of a lot of universities and colleges in Mediterranean & MENA region. He has great research profile of over 220 publications including several papers this year alone in top international journals. With a group of scientists he established new phenomenon in 2016  called “ Microbial Geographic Integration”. Which will be a mile stone the new field of ‘’ Geographic Medicine” He has great administration experience from a head of Department, blood banks and  Head of Staff office, to honor dean working with WHO- He assessed a lot of    universities in Gulf and other Arab states].    

 

Careers

                

1.     Family name:  Daw

2.     First names:  Mohamed Ali

3.     Date of birth: 1967

4.     Nationality:   Libya     

5.     Civil status: Married

6.     Education:   

Institution

[Date from - Date to]

Degree(s) or Diploma(s) obtained:

Dako Academy

 

2009  

 

 St James's Hospital, Training Course in Clinical Microbiology, Trinity College Dublin University, Dublin IRELAND 1985-1989

 

St James Hospital Central Lab and Blood bank

    

 PhD

 

Training Courses  ( 1985-87)

Department of Clinical Microbiology, St. James's Hospital  1998-1992

 

Postdoctoral-ship

 

 Royal college of Pathologist 1990

 

MRCpath (A)

 

  Member ship of Pathological Society( Extraordinary) 1987

 

 MPS

Trinity College Association( Alumoni) 1993

 FTCDA

Faculty of Medicine ,Tripoli-LIBYA   2000

 MD

Faculty of Pharmacy, Tripoli-LIBYA 1977-1982

 B Pharm

Supplementary Course in Biostatistics &  management 

 Trinity College 1989-1990

7.      Language skills: 

Language

Reading

Speaking

Writing

English

Excellent

Excellent

Excellent

French

Good

 Understandable

Good

Arabic

Excellent

Excellent

Excellent

8.     Membership of professional bodies: MPS, TCDA, HIS, ASCM, WAME,EMAMA, ESCMI ESGNI

9.     Other skills:               Computer, Internet

10.   Present position:        Professor of Clinical Microbiology and  Clinical Epidemiology , Acting    Physician of Internal Medicine& infectious Diseases

11.    Years within the firm: 1989 till now    

12.    Key qualifications:  (Relevant to the post), PhD, MD, MPS, B pharm, FTCDI, MRCpath (1A)

13.   Specific experience in similar position  the region:

 

Country

Date from - Date to

Libya

1993- till now

WHO-EMAME

Vice President at Large; Region 1; Egypt, Libya ,Tunis  Morocco,  Mauritania, Somalia, Djibouti

2009-till 2015

-       Vice president of EMAME-  2015

Eurpopean union(EU) Belgium 

2006, HIV, QC

 Africa

Short Visits ,( sharing Projects)2007

Ireland (EU)

1984-1993

Federation of Arab Societies fo Clinical Microbiology and Infectious Diseases

2012 (International Member )

Libya

1993- Libyan National Laboratory, Blood central Bank

Libya

 1996=2001, Blood Bank, Tripoli Central Hospital

 

14-Distinguished Scientific and Academic  Experience ( Invention and Leadership)

Subject

Date

Geographic Integration of Infectious Diseases; New theory for Global spread of Infectious diseases –HCV-a mode

2016; World Journal of Virology (WJV)

Libyan Journal of Medicine

2006, pubmed cited 2011, No in Africa& Arab  countries 2018)

Daw's Criterion

Geographic Integration of HCV

1990-1991

2016 on

Helicolycin- Helicobacter pylori

1992

 

 

 

 

 

 

 

 

 

 

 

 

 

15 International Leadership Professional experience:

DATE FROM –DATE TO

LOCATION

COMPANY

POSITION

DESCRIPTION

10/1993 – 9/2020[A1] [HD2] 

Tripoli, Libya

Tripoli Central Hospital

Senior Physician (Private & Public) Training NCD

·     Acting Physician in General Medicine( Daily practice);

·     Training of Local Doctors;

·     Visiting and training Consultant to Libyan hospitals and Faculties of Medicine across Libyan regions.

5/2013 – 10/2016

Malaysia, United Kingdom

University Putra Malaysia

Trainer, Supervisor (part-time)

Use of interferons in Chronic Hepatic Disease.

4/2010 – 10/2014

Manchester, United Kingdom

Sarford University

Trainer, Supervisor (part-time)

Community Antimicrobial Resistance and use of antibiotics.

10/2009 – 10/2013

Cardiff, United Kingdom

Wales University

Trainer, Supervisor (part-time)

Biostatistics and Public Health; Modelling chronic diseases and prospective planning.

9/2009 – 10/2010

Bahrain

Ministry of Health

Senior Teacher and  Family practitioner

Training  General  Practice and Senior Doctors for Family medicine, PHCC and NCD.

6/1993 – 102000

Tripoli, Libya

Faculty of Medicine, Tripoli University

Professor & Head of Medical Microbiology & Epidemiology

Teaching and supervising medical students, MSc, and PhD Students.

4/1989 – 9/1992

Dublin, Ireland

St James’s hospital

Lecturer

Department of Clinical Microbiology, St James’s Hospital.

4/1988 – 9/1989

Dublin, Ireland

Trinity College

Trainer in Public Health Planning (Diploma)-Diploma in Public Health( DPH)-NCD

Training of Medical Doctors on planning and writing of public health policies.

4/1987 –

9/1989

Dublin, Ireland

St James’s Hospital | St Patrick Research Lab

Senior Researcher

·     Focus on chronic ulcer diseases and HAI;

·     Worked in an international team and Irish National team; distinguished for excellent team work.

4/1986 – 10/1987

Dublin, Ireland

St James’s Hospital

Senior Doctor

Fellow in Hematology (Chronic diseases) and Hospital AI.

9/1982 – 12/1986

Tripoli / Benghazi, Libya

Ministry of Health

Public Health Trainee

Community Services.

 

 

 

 

 

 [A1]I assume it is since 1993 until today, right?

 [HD2]

Research Interests

PUBLICATIONS

 

Mohamed A Daw, MD,PhD, MPS, Phram D, FTCDI, MRCPath(1)A

Research-gate  - Performance 

-Over all publications; 321

- Documented publications; 240

 Research Interest Score                                                                     1,307

Citations                                                                                              1,839

h-index                                                                                                      24

 

Highest in Libyan Universities(1-2)

https://www.researchgate.net/profile/Mohamed_Daw2

 

Ranked No 1, The Highest  from all  African & Arab Universities-  a top reader attracti  over 3000,950  Readers

Google Scholar-  

https://scholar.google.com.ly/citations?user=70WDUrEAAAAJ&hl=en

Citation indices; The Highest in Libyan Universities

Cited by

All

Since 2017

Citations

1737

860

h-index

24

17

i10-index

46

32

 

 

PubMed, PubMed Central Medline ,

https://pubmed.ncbi.nlm.nih.gov/?term=Daw+MA&sort=date

 

 

 

 

 

 

 

Published Books ,

-M. A. Daw, “Transmission of hepatitis C Virus,” in Hepatitis C Virus: Molecular Pathways and Treatments, O. Stambouli, Ed., OMICS Group, Henderson, Nev, USA, 2014.

 

  1- Viral Hepatits in Libya; Clinical and Epidemiological Studies  Part 1, Triploi-Libya Daw MA,

2- Laboratory Manual for  Practical Microbiology,  Faculty of Medicine Tripoli-Libya Daw MA etal.,

3- Spring Verlag ; Germany Chapters in different books; 1990,1992,1993

 

Postgraduate Students Supervision and Teaching

 

1-    UNITED KINGDOM-UK 2008- till now (2017)

A -      PhD Supervision and Training ;

1-     Gallomogen University – United Kingdom

-            Epidemlogical manifestation of Hepatitis in Libya ; Model analysis

   Bouzedi, Gallomogen University, Bouzed A –  Professor Jamal Amin  

2-     Sarford University- United Kingdom

-        Studies on Molecular analysis of MRSA in Libya,         Sarford University , Warg S - Professor Tom Foster

2    MALAYSIA  -        2013- Till now (2017)

B-PhD Supervision and Training

1-University - Universiti Putra Malaysia

 

 

 Samia Ibrahim Adam,  Ph D-Title ;

 

 PREDICTORS OF HEALTH-RELATED QUALITY OF LIFE AMONG LIBYAN PATIENTS INFECTED WITH THE HEPATITIS C VIRUS

 

3-    Libya – 1993- 2018

1-Academy of Higher Studies –Libya

-       Clinical and Epidemiological Manifestation of Nosocmial Infection Manifestations , Mohamed Hassabrasoul – Mohamed Hasbarasoul- Chadian- M A Daw

2-Msc Students- Faculty of Medicine  

-       Seven Students 

 

Review Articles & original papers

2012-  till now

RESEARCCH TOPIC 2022

Front. Public Health, 05 September 2022 Sec. Disaster and Emergency Medicine https://doi.org/10.3389/fpubh.2022.1008883

 

EDITORIAL article

DAW MA. “[Armed conflicts; implications, dynamics and impacts on Public Health care services. Frontiers in Public Health.:3023.

Daw MA, El-Bouzedi AH, Ahmed MO. The Impact of Armed Conflict on the Prevalence and Transmission Dynamics of HIV Infection in Libya. Front Public Health. 2022 Mar 31;10:779778. doi: 10.3389/fpubh.2022.779778. PMID: 35433583; PMCID: PMC9009867.

Daw MA, El-Bouzedi A, Ahmed MO. The Epidemiological and Spatiotemporal Characteristics of 2019 novel coronavirus diseases (COVID-19) in Libya. Front. Public Health 2021-| doi: 10.3389/fpubh.2021.628211

DAW MA. The impact of armed conflict on the epidemiological situation of Coronavirus disease (COVID-19) in Libya, Syria, and Yemen. Mohamed A Daw. Frontiers in Public Health. 2021;9:698.

 

Daw MA, Daw AM, Miftah MM, El-Bouzedi A, Ahmed MO; Libyan Study Group of COVID-19 (LSG-COVID-19). Familial Clustering and Reinfection With 2019 Novel Coronavirus (COVID-19, SARS-CoV-2) in the Libyan Community. Disaster Med Public Health Prep. 2021 Mar 8:1-3. doi: 10.1017/dmp.2021.68. Epub ahead of print. PMID: 33678217; PMCID: PMC8134895.

 

Daw MA, Ahmed MO. Epidemiological characterization and geographic distribution of human immunodeficiency virus/acquired immunodeficiency syndrome infection in North African countries. World J Virol. 2021 Mar 25;10(2):69-85. doi: 10.5501/wjv.v10.i2.69. PMID: 33816152; PMCID: PMC7995411.

Daw MA, El-Bouzedi AH, Ahmed MO. How are countries prepared to combat the COVID-19 pandemic during the armed conflict?; The case of Libya. Travel Med Infect Dis. 2021 Jan 21:101977. doi: 10.1016/j.tmaid.2021.101977. Epub ahead of print. PMID: 33486055; PMCID: PMC7826110

 

Daw MA, Zgheel FA, El-Bouzedi A, Ahmed MO. Spatiotemporal Distribution of Tuberculosis and COVID-19 during the COVID-19 Pandemic in Libya. Disaster Med Public Health Prep. 2020 Nov 19:1-12. doi: 10.1017/dmp.2020.458. Epub ahead of print. PMID: 33208222

 

Mohamed Ali Daw et al. The epidemiological characteristics of COVID-19 in Libya during the ongoing-armed conflict. Pan African Medical Journal. 2020;37:219. [doi: 10.11604/pamj.2020.37.219.24993]

 

Daw MA, El-Bouzedi AH, Ahmed MO. COVID-19 and African immigrants in North Africa; A hidden pandemic in a vulnerable setting. Disaster Med Public Health Prep. 2020 Oct 19:1-6. doi: 10.1017/dmp.2020.387. Epub ahead of print. PMID: 33070803.

Daw MA, Sifennasr NE, El-Bouzedi A, Ahmed MO. A systematic review and meta-analysis of the prevalence, trends and spatiotemporal distribution of HIV/AIDS infection in Northern African countries AIDS Research & Therapy 2020.

Daw MA, El-Bouzedi AH, Ahmed MO. The Epidemiological and Spatio-temporal Characteristics of 2019 Novel Coronavirus Diseases (COVID-19) in Libya BMC Infectious Diseases 2020.

Daw MA, El-Bouzedi AH, Ahmed MO, Cheikh Y. Spatial Distribution and Geographic Mapping of COVID-19 in Northern African Countries; A Preliminary Study. J Clin Immunol Immunother. 2020;6:032.

Daw MA. Corona virus infection in Syria, Libya and Yemen; an alarming devastating threat. Trav Med Infect Dis. 2020 Apr 2;101652.

Daw MA, El-Bouzedi AH. Modelling the epidemic spread of COVID-19 virus infection in Northern African countries. Travel Medicine and Infectious Disease. 2020 Apr 15.

Daw MA. Preliminary epidemiological analysis of suspected cases of corona virus infection in Libya. Travel medicine and infectious disease. 2020 Mar 20.

Daw MA, Daw AM, Sifennasr NE, Draha A, Daw A, Daw A, Ahmed M, Mokhtar E, El-Bouzedi A, Daw I, Adam S. The epidemiological characterization and geographic distribution of Hepatitis D virus infection in Libya. The Pan African Medical Journal. 2020 Apr 14;35(120).

Daw MA. Corona virus infection in Syria, Libya and Yemen; an alarming devastating threat. Trav Med Infect Dis. 2020 Apr 2;101652.

Daw MA, El-Bouzedi AH. Trends and projection of demographic indices of the Libyan population using a fifty-year census data 1954-2016. African Population Studies. 2019 Aug 6;33(2).

Daw MA, Daw AM, Sifennasr NE, Draha AM, Daw AA, Daw AA, Ahmed MO, Mokhtar ES, El-Bouzedi AH, Daw IM, Adam SI. Spatiotemporal analysis and epidemiological characterization of the human immunodeficiency virus (HIV) in Libya within a twenty five year period: 1993–2017. AIDS research and therapy. 2019 Dec;16(1):14.

Ahmed MO, van Velkinburgh JC, Daw MA. Analysis of biomedical publications in Libya from 2003 to 2013. Education for Health. 2018 Sep 1;31(3):187.

Daw MA, El-Bouzedi AH, Dau AA. Trends and patterns of deaths, injuries and intentional disabilities within the Libyan armed conflict: 2012-2017. PLoS one. 2019 May 10;14(5):e0216061.

Daw MA, Ali LA, Daw AM, Sifennasr NE, Dau AA, Agnan MM, El-Bouzedi A. The geographic variation and spatiotemporal distribution of hepatitis C virus infection in Libya: 2007–2016. BMC infectious diseases. 2018 Dec;18(1):594.

Daw MA, Daw AM, Sifennasr NE, Draha AM, Daw AM, Daw AM, Ahmed MO, Mokhtar ES, El-Bouzedi A, Daw IM. The Epidemiology of Hepatitis D Virus in North Africa: A Systematic Review and Meta-Analysis. The Scientific World Journal. 2018;2018.

Daw MA. The Epidemiology of Hepatitis C virus infection in African immigrants; bridging the gaps. Travel medicine and infectious disease. 2018 Jun 12.

Kieffer N, Ahmed MO, Elramalli AK, Daw MA, Poirel L, Álvarez R, Nordmann P. Colistin-resistant carbapenemase-producing isolates among Klebsiella spp. and Acinetobacter baumannii in Tripoli, Libya. Journal of global antimicrobial resistance. 2018 Jun 1;13:37-9.

Daw M.A. Hepatitis C in North Africa (Arabic Maghreb Region). In: Kamal S.M., editor. Hepatitis C in Developing Countries: Current and Future Challenges. Elsevier: Academic Press; 2018:57–70. ISBN: 9780128032336

 

Daw, Mohamed A. "Libyan healthcare system during the armed conflict: Challenges and restoration." (2017).African Journal of Emergency Medicine  Vol 3; 2017

Daw MA, El-Bouzedi A, Ahmed MO, Dau AA; In association with the Libyan Study Group of Hepatitis & HIV. Molecular and epidemiological characterization of HIV-1 subtypes among Libyan patients.  BMC Res Notes. 2017 Apr 28;10(1):170. doi: 10.1186/s13104-017-2491-2

Daw MA, Sifennasr NEM, El-Bouzedi A, Daeke AO, Dau AA, Drah AM, Ahmed MO, Agnan MM. Epidemiology of hepatitis B virus in immigrants crossing to Europe from North and Sub-Saharan Africa. Travel Med Infect Dis. 2017 Mar - Apr;16:59-61. doi: 10.1016/j.tmaid.2017.01.006. Epub 2017 Jan 31. No abstract available.

Ahmed MO, Baptiste KE, Daw MA, Elramalli AK, Abouzeed YM, Petersen ASpa typing and identification of pvl genes of meticillin-resistant Staphylococcus aureus isolated from a Libyan hospital in Tripoli. J Glob Antimicrob Resist. 2017 Jul 19;10:179-181. doi: 10.1016/j.jgar.2017.06.004.

Ahmed MO, Daw MA, van Velkinburgh JC. An evolving research culture: Analysis of biomedical publications from Libya, 2003–13. Research Evaluation. 2017 Aug 30.

Adam SI, Said SM, Daw MA, Khalid B, Shahar H. Predictors of Non-Adherence of Hepatitis C Patients to Treatment: A Systematic Review.

Samia IA, Salmiah MS, Mohamed AD, Bahariah K, Hayati KS. PREDICTORS OF HEALTH-RELATED QUALITY OF LIFE AMONG LIBYAN PATIENTS INFECTED WITH THE HEPATITIS C VIRUS. International Journal of Public Health and Clinical Sciences. 2017 Aug 16;4(4).

 

M. A. Daw, A. El-Bouzedi, and A. A. Dau, “The assessment of efficiency and coordination within the Libyan health care system during the armed conflict-2011,” Clinical Epidemiology and Global Health, 2015.

 

M. A. Daw, A. El-Bouzedi, and A. A. Dau, “Libyan armed conflict 2011: mortality, injury and population displacement,” African Journal of EmergencyMedicine, vol. 5, no. 3, pp. 101–107, 2015.

 

Daw MA, El-Bouzedi A, Ahmed MO, Dau AA, Agnan MM, Drah AM, et al. Prevalence of human immune deficiency virus in immigrants crossing to Europe from North and Sub-Saharan Africa. Travel Med Infect Dis. 2016;14:637–8.

 

Daw MA, El-Bouzedi A, Ahmed MO, Dau AA, Agnan MM. Hepatitis C virus in North Africa: an emerging threat. Sci World J. 2016;2016:7370524.

 

M. A. Daw, A. El-Bouzedi, M. O. Ahmed, A. A. Dau, M. M. Agnan, and A.M. Drah, “Geographic integration of hepatitis C virus: a global threat,” World Journal of Virology (WJV), 2016.

 

M. A. Daw, A. El-Bouzedi, M. O. Ahmed, A. A. Dau, and M. M. Agnan, “Epidemiology of hepatitis C virus and genotype distribution in immigrants crossing to Europe from North and sub-Saharan Africa,” Travel Medicine and Infectious Disease, 2016.

 

M. A. Daw, A. Shabash, A. El-Bouzedi, A. A. Dau, M. Habas, and Libyan-Study-Group-of-Hepatitis-and-HIV, “Modelling the prevalence of hepatitis C virus amongst blood donors in Libya: an investigation of providing a preventive strategy,” World Journal of Virology, vol. 5, no. 1, pp. 14–22, 2016.

 

M. A. Daw, A. El-Bouzedi, and A. A. Dau, “Geographic distribution of HCV genotypes in Libya and analysis of risk factors involved in their transmission,” BMC Research Notes, vol. 8, article 367, 2015.

 

Daw MA, El-Bouzedi A. Viral haemorrhagic fever in North Africa; an 522 evolving emergency. J Clin Exp Pathol 2015;5, 2161-0681.

 

M. A. Daw, A. Shabash, A. El-Bouzedi, and A. A. Dau, “Seroprevalence of HBV, HCV & HIV co-infection and risk factors analysis in Tripoli-Libya,” PLoS ONE, vol. 9, no. 6, Article ID e98793, 2014.

 

 

M. A. Daw and A. El-Bouzedi, “Prevalence of hepatitis B and hepatitis Cinfection in Libya: results froma national population based survey,” BMC Infectious Diseases, vol. 14, article 17, 2014

 

Daw MA, Elasifer HA, Dau AA and Agnan M. The role of hepatitis C virus genotyping in evaluating the efficacy of INF-based therapy used in treating hepatitis C infected patients in Libya. Virol Discov. 2013; 1:3 http://dx.doi.org/10.7243/2052-6202-1-3

 

M. A. Daw, A. A. Dau, and M. M. Agnan, “Influence of healthcare- associated factors on the efficacy of hepatitis C therapy,” The Scientific World Journal, vol. 2012, Article ID 580216, 8 pages, 2012.

.

Daw MA, Dau AA. Hepatitis C in Arab world ; A State of concern. The Scientific World Journal.2012 ID 719494, 12 pages

Dau AA, Tloba S, Daw MA.  Characterization of wound infection among injured patients during Libyan conflict. Eastern Mediterranean Health Journal ; 2012 – 5 pages

Daw MA Dau AA, Elasifer H, Tloba S. Emergence of multiresistant Acintobacter baumannii among Libyan military personnel during the recent conflict . Clinical Infection; 2012; P 1250- ESCMID- London

 

 

Before 2012

- Hana A Elasifer, Yossif M Agnnyia, Basher A Al-Alagi, Mohamed A Daw* Epidemiological manifestations of hepatitis C virus genotypes and its association with potential risk factors among Libyan patients Virology Journal 2010, 7:317 http://www.virologyj.com/content/7/1/317

 

-Shabash A, Habas M, Fara A, Daw M: Epidemiological analysis of potential risk factors contributes to infection of HBV, HCV and HIV among the population in Tripoli Area, Libya. Clinical Microbiol Infection 2010, 16(S2):120.

 

- Elasifer H, Elagy B, Eltaghdy M, Draah A, Daw M: The influence of HCVgenotypes and other predicting factors in virological response in patients treated with INF alpha or PEG INF alpha 2a in combination with  ribavirin’. Clinical Microbiol Infection 2010, 16(S2):121.

 

. Shabash A, Habas M, Alhajrasi A, Furarah A, Bouzedi A, Daw M: Forecast modeling for prediction of hepatitis B and Hepatitis C seropositivity among Libyan population. Clinical Microbiol Infection 2010, 16(S2):120.

 

Shabash A, Habas M, Fara A, Daw M. Epidemiological ananlysis of potential risk factors contributing to infection of HBV,HCV, and HIV among the  population of  Tripoli Libya, Clinical Microbiol Infection 2010 16(S2) 125.

 

Daw MA. The impact of publication in the Libyan Journal of Medicine on the International recognition  of the Libyan research 5 th Regional Conference of Medical Journals. Eastern Mediterranean Region  Karachi Pakistan

 

Daw MA.  Open access publication; Its motivation and impact on Medical research. 4 th Regional Conference of Medical Journals. Eastern Mediterranean Region  Manama-Bahrain; November 2008; 5-7th

 

 Bagasra O, Alsayari M, Bullard-Dillard R, Daw MA. 2007. The Libyan HIV outbreak: How do we find the truth? Libyan J Med. 2007; 2:AOP: 070221

 

 

 

Daw MA, Elkhmmas EA, Libyan Medical education ; time to move forward (2008) Libyan Journal of Medicine

Daw, MA, Mihat AA, Werflli MM, Sila IM and Elsbeia H. (2002): Prevalence of hepatitis C virus antibodies among different populations vary in relative and ttributable risk. Saudi Medical Journal (Submitted)

 

Daw, MA and Drah AM.(2001): Antibiotic resistance :prospects for the new millenium. Journal of Chemotherapy. 13; 42-49

Daw MA, Elwarvelli  MM, Siala IM, Backush M and Elussabie H.(2001): Prevalence of HbsAg among Libyan populations: a comparative study. Annals of Saudi Medicine 21;130-132

Daw MA, Siala IM, Wafalli Mwand Muftah MI.(2000).Seroepidemiology of hepatitis B virus markers among hospital health care workers; analysis of certain potentioal risk factor. Saudi Medical Journal, 21;1157-1160

Daw, M. A., Nagat Saeed and Mughuer H. (1997): Prevention of Intravenous Catheters Associated Infection. Postgraduate Doctor, 20(2):48-53.

Daw, M. A. and Falkiner F.R., (1996): Bacteriocins; Nature, Function and

Structure MICROM (International Journal of Research and Microscopy),  27:467-479.

Daw, M. A. and Falkiner F.R., (1994): Prevention of Gram-negative Infection in Neutropenic Cancer Patients. Saudi Medical Journal, 15(3):196-203.

O’Morain, C., Collins, R. and Daw, M. A., McCarthy C., (1991): Helicobacter pylori and Peptic Disease. Journal of Biomedical Science, 1:204-210.

Daw, M. A., MacMahon, E. and Keane, C.T. (1988): Surveillance Culture in Neutropenic Patient. Journal of Hospital Infection, 1988, 12:251-261.

**** (Recommended to be No. 1 of outstanding interest, in Current Opinions of Infectious Diseases, 1990 3:205).

 

Supplements to Journals

Focus on infectious diseases-Infectious Diseases Supplement

Daw MA, Ghenghesh K Elzubidi I, and Piero (2001).  Hepatitis G virus: a true hepatotropic virus ?. Postgraduate Doctor 24;20-24

Daw MA, Elzubidi I, Ghenghesh K and Piero S. (1999). Hepatitis B virus : pathogenesis and clinical aspects. Postgraduate Doctor, 22;15-20

Daw MA, (In preparation). Burdens of Hepatitis C virus infections on the developing countries. Postgraduate Doctor

Letters to the Editor:

Daw MA.(1999); Clinical and epidemiological features of Pseudomnas aeruginosa infection at the Libyan hospitals. Saudi Medical Journal;20:646-649

Daw, M. A., Sief-Alnasar, N., Hussan, M. H. and O’Morain, C. (1997): Pattern of Helicobacter pylori Resistance to Antimicrobials. Saudi Medical Journal, 1997, 18:526-527

 

 

 

Medical education-Correspondence 

Daw MA. (2002). Going beyond the curriculum to promote medical education and practice. Saudi Medical Journal.23;806-807

Daw MA.(1999). New features in the Saudi Medical journal. Saudi Medical Journal 20;819

Chapters in published books:

Daw, M. A. Xia, H. X. and O’Morain, C.(1994): Helicobacter pylori, phospholipase C and haemolysis. In Basic and Clinical Aspects of Helicobacter pylori Infection, Edited by Gasbarrini and Pretolani. Springer-Verlag Berlin Heidelberg. pp. 85-89.

**** Helicolysin was firstly described in this paper.

O’Morain, C., Xia, H.X. and Daw, M. A. (1994): Clinical application of antibiotics in eradicating H pylori. Basic and Clinical Aspects of Helicobacter pylori Infection, Edited by Gasbarrini and Pretolani. Springer-Verlag Berlin Heidelberg. pp. 283-289

Daw, M. A. O’Moore, R.  and O’Morain, C. (1993): Detection of Phospholipases and Cytotoxic activities of Helicobacter pylori. In Helicobacter pylori and Gastroduodenal Pathology edited by J.M.Pajares etal., Springer-Verlag Berlin Heidelberg. pp. 101-106.

Original papers , Abstracts & Invited talks:

Daw, M. A., MacMahon, E., Munnelly, P., Falkiner, F.R. and C. T. Keane; Surveillance Culture in the Management if Neutrioenic Patients.

The Proceeding of the First International Conference of the Hospital Infection Society, London, September, 1987, O7/3 (in London).

Daw, M.A., Falkiner, F.R. and Keane, C.T. (1987): Enterobacter Infections in Neutropenic Host. Meeting of the Irish Society of Clinical Microbiologists, Dublin, October 1987 (Dublin-IRELAND).

Daw, M.A., Munnelly, P. MacMahon, E. Falkiner F.R. and Keane, C.T. (1988): Value of Surveillance Culture in the Management of Neutropenic Patients. European Journal of Clinical Microbiology and Infectious Diseases, 7:742-747.

**** Recommended as No. 3 of an outstanding interest: In Current Opinions of Infectious Diseases, 1990, 3:205.

Daw, M.A., Falknier, F.R. and Keane, C.T. (1988): Epidemiology of Enterobacter cloacae. Irish Society of Clinical Microbiologists, Spring Meeting, April 1988, Limerick, IRELAND.

Daw, M.A., Falknier, F.R. and Keane, C.T. (1989): Typing of Enterobacter cloacae by using SDS- Polyacrylamide Gelelectrophoresis. The proceedings of the Fourth European Congress of Clinical Microbiology, April 1989, Nice, France.

 

Daw, M.A., Scott, T., Falkiner, F.R. and Keane, C.T. (1989): Haemagglutination and Tissue Culture Adherence of Enterobacter cloacae. Irish-Welsh Societies of Microbiology Meeting, September 1989, Trinity College, Dublin, IRELAND.

**** Winner of the Posters Section (First Prize).

Daw, MA. (1989): Epidemiology of Gram-negative bacilli in Neutropenic Patients with particular referance to Enterobacter cloacae. Ph.D. Thesis, Trinity College, 1989, Dublin, IRELAND.

Deegan, P.B., Beattie, S., Daw, M.A. and O’Moran, C. (1990): Omeprazole Inhibits Helicobacter pylori. Irish Journal of Medical Science, 159:317.

Patchett, S., Beattie, S., Daw, M.A., Leen, E., Keane, C.T. and O’Morain, C. (1990): Towards the Optimum Therapy of Helicobacter pylori associated peptic ulcer disease. Irish Journal of Medical Sciences, 159:317.

O’Morain, C., Mathai, E., Daw, M., Keane, C. and O’Moore, R. (1990): Lipolytic Activity of Helicobacter pylori. Gastroenterology, S98:A101.

Daw, M.A., McCann, S., Daly, P.A., Falkiner, F.R. and Keane, C.T. (1990): Bacterial Translocation and Gram-negative Bacteraemia in Neutropenic Patients. Proceedings of the Second International Conference of Hospital Infection Society, (London), September 1990, P71-81.

Daw, M.A., McCann, S., Daly, P., Falkiner, F.R. and Keane, C.T. (1990): Epidemiology of Gram-negative Infections in Neutropenic Patients; A Three Year Prospective Study. Proceedings of the Second International Conference of Hospital Infection Society, (London), September 1990, P72-81.

Daw, M.A., Deegan, P., Beattie, S. Leen, E., Keane, C.T. and O’Morain, C. (1990): Suppression of Helicobacter pylori during the Clincal Use of Omeprazole. Gut; 31:A1199.

Daw, M.A., Cotter, L., Healy, M., O’Moore, R., Keane, C.T. and O’Morain, C. (1990): Phospholopases and Cytotoxic Activity of Helicobacter pylori. Revista Espanola de Enfermedades Digestives, 1990, S1:25-26.

Daw, M.A., O’Moore, R., Keane, C.T. and O’Morain, C. (1990): Studies on Phospholopases and Cytotoxic Activities of Helicobacter pylori. Proceedings of the Irish Society of Gastroenterology, November 1990, Galway, IRELAND.

Peabhakar, M.C., Daw, M.A., Keane, F. and O’Morain, C. in Vivo Effect of Bile Salts on Helicobacter pylori. Proceedings of the Irish Society of Geastroenterology, Dublin, November 1990, IRELAND.

Daw, M.A., Corcorcon, D., Falkiner, F.R. and Keane, C.T. (1992): Application and Assessment of Cloacin Typing of Enterobacter cloacae. Journal of Hospital Infection, 20:141-151.

**** Criterion of Daw is Firstly mentioned in this paper.

Daw, M.A., Deegan, P., Leen, E. and O’Morain, C. (1991): the Effect of Omeprazole on Helicobacter pylori and Associated Gastritis. Journal of Alimentary Pharmacology and Therapeutics, 5:435-439.

Daw, M.A., Cotter, L., Healy, M., O’Moore, R., Keane, C.T. and O’Morain, C. (1991): Are Helicobacter pylori Strains Isolated from Duodenal Ulcer more Virulent than those Isolated from Gastritis? Geastroenterology, 100:A572.

 

Xia, H.X., Daw, M.A., Keane, C.T. and O’Morain, C. (1991): Resistance of Helicobacter pylori to Metronidazole; a prospective study. Proceedings of the Irish Society of Geastroenterology, Dublin, 7-8 June 1991, IRLEAND.

Xia, H.X., Daw, M.A., Keane, C.T. and O’Morain, C. (1991): The Value of Rapid Urease Test in Reading Minimum Inhibitory Concentration of Antibiotics to Helicobacter pylori. Proceedings of the Irish Society of Geastroenterology, Dublin, 7-8 June 1991, IRLEAND.

Daw, M.A., Scott, T., Falkiner, R. and Keane, C.T. (1991): Adherence Properties of Enterobacter cloacae. Journal of Medical Microbiology, 1991, 35:IX.

Daw, M.A. and Falkiner, F.R. (1991): Characterization of Bacteriocins Isolated from Enterobacter cloacae. Journal of Medical Microbiology, 1991, 35:IX.

Xia, H.X., Daw, M.A., Keane, C.T. and O’Morain, C. (1991): Helicobacter pylori; Emergence of Metronidazole Resistant Isolates. Journal of Medical Microbiology, 1991, 35:IX.

Cotter, L., Healy, M., Daw, M.A., Keane, C., Weir, D.G. and O’Moore, R.R. (1991): The Possible Role of Bacteroides Melaninogenicus Phospholipases in the Pathogenesis of Contaminated Small Bowel Syndrome. Journal of Medical Microbiology, 1991, 35:VIII.

Daw, M.A., O’Moore, R., Keane, C.T. and O’Morain, C. (1991): Phospholioase C Activity; New Pathogenicity Marker for Helicobacter pylori. Italian Journal of Geastroenterology, 23:38.

Daw, M.A., O’Moore, R., Keane, C.T. and O’Morain, C. (1991): Phospholioase C Haemolytic Activity of Helicobacter pylori. Italian Journal of Geastroenterology, 23:37-38.

Xia, H.X., Daw, M.A., Keane, C.T. and O’Morain, C. (1991): Induction of Helicobacter pylori resistance to Metronidazole and Tetracycline in Vitro. Italian Journal of Geastroenterology, 23:49.

Xia, H.X., Daw, M.A., Keane, C.T. and O’Morain, C. (1991): Interaction between Metronidazole and Tetracycline against Sensitive and Resistant Isolates of Helicobacter pylori. Italian Journal of Geastroenterology, 23:49.

Daw, M.A. and O’Morain, C. (1991): The Cytolytic Activity of Helicobacter pylori. Invited Talk: IV Workshop on Gastroduodenal Pathology and Helicobacter pylori. November 28-30/1991, Bologna, Italy.

Xia, H.X., Daw, M.A., Keane, C.T. and O’Morain, C. (1992): Establishment of Interpretative Standard for Susceptibility Teating of Metronidazole against Helicobacter pylori. Proceedings of the Pathological Society of Great Britain and Ireland, January 1992, North Ireland, Britain.

Daw, M.A. (1992): Enterobacter cloacae; an emerging problem in immunocompromised patients. Proceedings of the Pathological Society of Great Britain and Ireland, January 1992, North Ireland, Britain.

 

Xia, H.X., Daw, M.A., Keane, C.T. and O’Morain, C. (1992): Eradication of metronidazole-resistant Helicobacter pylori and healing of duodenal ulcer. The Inaugural National Scientific Medical Meeting, 1992, IRELAND.

 

Xia, H.X., Daw, M.A., Beattie, S., Keane, C.T. and O’Morain, C. (1992): The Influence of Metronidazole Resistance on Triple Therapy for Helicobacter pylori. Geastroenterology, 102:A947.

Daw, M.A. with others (1991): Metronidazole Resistance in Helicobacter pylori: Results of the Second Multi-center in Vitro Study. Italian Journal of Geastroenterology, 1991, 23-27.

Daw, M.A., and O’Morain, C. (1992): Studies on the Haemokytic Activity of Helicobacter pylori. Proceedings of the Irish Society of Geastroenterology. Galway, IRELAND, June 1992.

Daw, M.A., Falkiner, F.R. and Keane, C.T. (1992): Gram-negative Bacilli; its Pathogenicity in Neutropenic Patients. Proceedings of Clinical Microbiology, New Prospective, Joint Meeting (AMM/BSAC/HIS/ISCM), Dublin-June 1992, 9.

Daw, M.A., Xia, H.X. and O’Morain, C. (1992): Characterization of the Haemolytic Activity of Helicobacter pylori. Irish Journal of Medical Science, 161, (S10) V48 5th Workshop on Gastroduodenal Pathology and Helicobacter pylori.

Xia, H.X., Daw, M.A., Keane, C.T. and O’Morain, C. (1992): Evaluation of a Medium to Maintain Survival of Helicobacter pylori. Irish Journal of Medical Science, 161(S10) V49. Workshop on Gastroduodenal Pathology and Helicobacter pylori.

Xia, H.X., Daw, M.A., Keane, C.T. and O’Morain, C. (1992): Resistance in Helicobacter pylori to Metronidazole in Dyspeptic Patients. Irish Journal of Medical Science, 161(S10) V5. Workshop on Gastroduodenal Pathology and Helicobacter pylori.

Xia, H.X., Daw, M.A., Keane, C.T. and O’Morain, C. (1992): Metronidazole Resistance in Helicobacter pylori and Antimicrobial Trials. Irish Journal of Medical Science, 161(S10) V95. Workshop on Gastroduodenal Pathology and Helicobacter pylori.

Sant, S., Xia, H.X., Daw, M.A., Keane, C.T. and O’Morain, C. (1992): Antimicrobial Therapy for Helicobacter pylori associated Duodenal Ulcer; a Long Term Follow-up. Irish Journal of Medical Science, 161(S10) V5. Workshop on Gastroduodenal Pathology and Helicobacter pylori.

Xia, H.X., Daw, M.A., Keane, C.T. and O’Morain, C. (1992): Transport Media for Helicobacter pylori. Journal of Medical Microbiology, 37:S1; 279.

Daw, M.A., Xia, H.X. and O’Morain, C. (1992): The Influence of Phospholipases Levels on the Haemolytic Activity of Helicobacter pylori, 1992, Shanghai International Symposium on Geastroenterology – China (abstract submitted).

Xia, H.X., Daw, M.A., Keane, C.T. and O’Morain, C. (1992): Eradication of Metronidazole Resistance Helicobacter pylori in Duodenal Ulcer Patients with Triple Therapy, 1992, Shanghai International Symposium on Geastroenterology – China (abstract submitted).

Daw, M.A. (1993): Hospital Acquired Infection, XVI International Annual Ain Shames Medical Congress, Infection and Disease, April 5-8 1993 Cairo, Egypt, pp. 129.

Daw, M.A. and O’Morain, C. (1994): Seroprevalence of Helicobacter pylori Infection in North African Countries with Particular Reference to Libya .Acta Gastroenterlogica Belgium

 

Daw, M.A. etal. (1993): Prevalence of Hepatitis B Virus among the Libyans, 1993. The proceedings of the third International Conference of Hospital Infection, London, September 1993, Britain.

Daw, M.A. etal. (1993): Clinical Impact of Antimicrobial Resistance at Tripoli Teaching Hospitals. The Third International Conference of Hospital Infection, London, September 1993, Britain.

Daw, M.A. etal. (1994): Prevalence of Nosocomial Infection at Tripoli Teaching Hospitals. Seventh European Conference of Clinical Microbiology and Infectious Diseases, 1994, Vienna, Austria.

Xia, H.X., Daw, M.A., Sant, S., Beattie, S.,  Keane, C.T. and O’Morain, C. (1993):  Clinical Efficacy of Triple Therapy in Helicobacter pylori-Associated Duodenal Ulcer. European Journal of Clinical Gastrenterology & Hepathology, 5:141-144.

Elmasrati, H. M. and Daw, M.A. (1994): Role of Helicobacter pylori in Duodenal Ilcer Diseases. Second Libyan Congress of Medical Sciences, P92, May 8-11 1994, Benghazi, Libya.

Ghenghesh, K.S., Abed, S., Bara, F., Bukris, B., Elsurmani, A. and Daw, M.A.; Rotaviruses and Gastroenteritis in Libyan Children. Second Libyan Congress of Medical Sciences, p. 131, May 8-11 1994, Benghazi, Libya.

Ghenghesh, K.S., Abed, S., Bara, F., Bukris, B., Elsurmani, A. and Daw, M.A. (1994): Isolation of Campylobacter Species from Libyan Children with Diarrhea. Second Libyan Congress of Medical Sciences, p. 132, May 8-11 1994, Benghazi, Libya.

Elbakoush, O.M. and Daw, M.A. (1994): Rickettsiosis in Zliten Area. Second Libyan Congress of Medical Sciences, p. 220, May 8-11 1994, Benghazi, Libya.

Daw, M.A. etal. (1996): Seroprevalence of Hepatitis B Viruses among Libyans; a Five-Year Prospective Study. Egyptian Society of Medical Microbiology, October 1995 and the Third Libyan Congress on Medical Sciences, Tripoli 31 May to 3 April 1996, Libya.

Dekna, M., Aborawi, A., Smida, K., Fiteuri, H. and Daw, M.A. (1996): Impact of Nosocomial Infection on the Mortality of Neonates. The Third Libyan Congress on Medical Sciences, Tripoli 31 May to 3 April 1996, Libya.

Daw, M.A. and Ghenghesh, K.S. (1996): Pyocin Typing of Pseudomonas aeruginosa Isolated from Wound Infections. The Third Libyan Congress on Medical Sciences, Tripoli 31 May to 3 April 1996, Libya.

Daw, M.A., Nass, T.M. and Maghur, H., etal., (1996): The Impact of Methicillin (Multiple) Resistant Staphylococcous aureus (MRSA) on Teaching Hospitals. The Third Libyan Congress on Medical Sciences, Tripoli 31 May to 3 April 1996, Libya.

Ghenghesh, K., Elkabroun, M., Toloba, S., Rahouma, A., and Daw, M.A. (1995): Susceptibility of Pseudomonas aeruginosa Isolated from Wound Infections to Monospors. The Third Meeting for the Libyan Surgeons Society, 3-6 October 1995, Sabrata, Libya.

Ghenghesh, K., Elgumati, M., Abeid, S. and Daw, M.A. (1995): Cholera-like Diarrhea due to Aeromonas Caviae. The proceedings of the European Conference on Tropical Medicine, Hamburg, Germany, 22-26 October 1995, A105, pp. 11.

 

Daw, M.A., Bakoush, O. and Ghenghesh, K.(1997),: Clinical and Epidemiological Manifestation of Mediterranean Spotted Fever. Clinical Microbiology and Infection, 3(2); 341; p. 1375.

Abeid, S., Ghenghesh, K. and Daw, M.A. (1997): Antibiotics Resistance and B-lactamase Production by Salmonella and Shigella Isolated in Tripoli, Libya. Clinical Microbiology and Infection, 3(2); 341; p. 1216.

Daw MA, Tloba S,Elzubidi I, Ghenghish G.(1998). Prevalence of Methacillin resistant Staphyloccous aureus (MRSA) at Tripoli hospitals. Journal of Hospital Infection,40(sup A);P.3.1.2.11

Dekna M, Mletan S,Shaban A, Aburawi A and Daw MA.(1998).Sequential emergence of multiresistant Gram-negative Bacilli & neonates mortality. Journal of Hospital Infection,40(sup A);P.3.3.25.

Maghur H, Nuri A and Daw MA.(1989) Evaluation of intravenous catheter associated infections (CAI)in a cardio-surgery unit. Journal of Hospital Infection,40(sup A);.P.8.1.2.

Naas T and Daw MA. A preventive strategy of MRSA among Libyan hospitals (1998). Second International Meeting on the  Therapy of Infection-Florence, Italy November18-21,1998, A15

Ghenghesh K, Tloba S, Rahouma A, Daw MA etal., (1998). Second International Meeting on the  Therapy of Infection-Florence, Italy November18-21,1998,  A28

*** Over 15 contributions in Arabic Language in the field of Medicine and Infectious Diseases

 

 

                                INTERNATIONAL JOURNAL PARTICIPATION

 

On the Editorial Board of

1- Bahrain Journal Medical Association- Bahrain-Manama

2-BIOTECH LAB INTERNATIONAL

Globetec Publishing UK

Reviewer to;  A reviewer to over 21 Medical journal including the following top 10-

-       British Medical Journal-Open,-UK,

-       PLOS-one USA

-       BMC Infectious Diseases- UK

-       BMC public Health- UK

-       Journal of Medical Microbiology-UK

-       BMC Research Notes-UK

-       Travel & Infectious Diseases

-       Virology Journal USA

-       Journal of Ageing - UK

-       Saudi Medical Journal- KSA

Armed Forces Hospital P O Box 7898, Riyadh, Kingdom of Saudi Arabi

       -Journal of Chemotherapy- Italy

Florence, Italy, Mary Forest (Managing Editor)

 

 

CONFERENCES AND WORKSHOPS ORGANIZATION

 

Bahrain Manama  Work shop; Open Access Medical Education,  Coordinator&Speaker

First Libyan Workshop on Medical writing, Tripoli-Libyan Journal of Medicine

Second Workshop on research and Medical writing Benghazi, Faculty of Medicine

First Libyan Workshop on Bird Low and SARS

Faculty of Medicine, Tripoli,

First International Workshop on Nonsocial Infection and Hospital Hygiene

Tripoli Medical Centre, 2002

International Symposium on Tuberculosis

Tuberculosis; New Challenges

Tripoli;12-13 May 2001

Scientific coordinator; Daw MA

Blood Banking and Blood screening and policy  1994, Tripoli

 

 

MULTICENTRE STUDY PARTICIPATION

 

4-First Libyan National Study on the Epidemiology of HIV and Hepatitis; Large study in the world 2004 2006 (Coordinator)

 

3 -Libyan -Italian cooperation on Mycobacterium tuberculosis

Sassri University, Department of Microbiology,

Professor Stefani Zanetti

2- Metronidazole Resistance in Helicobacter pylori

Coordinator:  Dr. Y. Glupczynski

Department of Medical Microbiology

Brugmann University Hospital

Brussels, Belgium

1- Serology Study Group for Helicobacter pylori

Coordinator:  Prof. Roger A. Feldman

Department of Epidemiology & Medical Statistics

London Hospital Medical College

England at QMW, Mile End Road, London, E1 4NS

Tel: 0071 9826386, Fax: 0071 982639

 

MEETINGS ATTENDED

 

Pathological Society of Great Britain and Ireland, Dublin, June 1986.

Irish Society of Clinical Microbiology, Dublin, Ireland, October 1987 (speaker).

Irish Society of clinical Microbiology, Limerick, Dublin, Ireland, April 1988 (speaker).

First International Conference on Hospital Infection, London, September 1987 (speaker).

4th European Congress on Clinical Microbiology, Nice, France, April 1989 (speaker).

Irish-Welsh Meeting on Microbiology, Dublin, Ireland, September 1989 (speaker).

Second Meeting of the European Campylobacter Pylori Study Group, Ulm, Germany, October 1989.( Speaker)

Helicobacter pylori Workshop Group, Leeds, England, February 1990.(Speaker)

Irish Society of Gastroenterology, Limerick, Ireland, May 1990 (speaker).

Second International Conference on Hospital Infection, London, UK, 2-6 September 1990 (speaker).

British Society of Gastroenterology, Southampton, England, 26-28 September 1990 (speaker).

 

Third Workshop on Gastroduodenal Pathology and Helicobacter pylori, Toledo, Spain, 8-10 November 1990 (speaker).

Irish Society of Gastroenterology, Dublin, Ireland, 23-25 November 1990 (speaker).

Fourth Workshop of Gastroduodenal Pathology and Helicobacter pylori, November 28-30 1991, Bologna, Italy.(Speaker)

Inaugural National Scientific Medical Meeting, March 13-14 1992.

Irish Society of Gastroenterology, Galway, Ireland, May 1992 (speaker).

Clinical Microbiology: New Prospectives, Joint Meeting (AMM/BSAC/HIS/ISCM), June 24-26 1992, Dublin, Ireland (speaker).

Fifth Workshop of Gastroduodenal Pathology and Helicobacter pylori, July 2-4 1992, Dublin, Ireland (speaker).

Irish Microscopical Society, July, Dublin, Ireland (speaker).

Sixth Workshop of Gastroduodenal Pathology and Helicobacter pylori, September 18-23 1993, Brussels, Belgium (speaker).

Third International Conference on Hospital Infection Society Meeting, London, September 3-7 1993 (speaker). 

Second Libyan Congress on Medical Sciences, Benghazi, May 8-11 1994 (speaker).

Third Libyan Congress on Medical Sciences, Tripoli, May 31 to April 3 / 1996 (speaker).

European Congress on Clinical Microbiology and Infectious Diseases, Lausane, Switzerland, May 25-28 1997,(speaker).

Second International Meeting on the  Therapy of Infection-Florence, Italy November18-21,1998,  (speaker)

The cooperation between developing and developed Universities , organized by Sardegnia goverments and Sassiri University, Sardegnia,-Italy October,1999 (Speaker).

International symposium on Tuberculosis, tuberculosis; new challenge

Faculty of Medicine,Tripoli-Libya; May 12-13,2001( speaker &organizer)

Fifth Libyan National conference on Medical sciences, Tripoli, November,7-9,2001 (speaker &chair)

Sixth Libyan National conference on Medical sciences, Tripoli,  2004 

Eurpean Congress of Clinical Microbiology, Lusan Switzerland 2006(Speaker)

European Congress of Clinical Microbiology, Austria Vienna 2010 ( Speaker)

European Congress of Clinical Microbiology, London 2012 ( Speaker)

East rain Meditrrian  Society , Bahrain Manama 2009 ( Speaker)

Easterain Medetrian Society , Karachi Pakistan   2010 ( Speaker)  

     

        

        

 

 

 

AWARDS

 

Scientific Awards:             First Prize for best presentation, September 1989,

                                               Irish-Welsh Microbiology Societies Meeting,

                                                                Trinity College, Dublin, IRELAND.

Best Poster Presentation;               Toledo Spain- European Society of helicobacter Pylori 1991

Best Work Shop;                                Manama Bahrain, Eastern Mediterranean Regional Conference November 2008

General Awards:                University Cup for best speech, April 1980.

Best Department                               Award;  Faculty of Medicine, 1997

  

 

SOCIETIES MEMEBERSHIPS

 

 

American Society for Microbiology 1986.

European Society for Clinical Microbiology and Infectious Diseases, 1993, on going.

Association of Clinical Pathologists (Extraordinary Membership) 1991.

Hospital Infection Society, 1993, on going.

European Study Group of Epidemiological Markers, 1996, on going.

European Group of Studying Helicobacter pylori, 1989, on going.

European Study Group of Nosocomial Infection, 1997, on going.

Trinity College Trust-Libyan Branch (The Person in Contact), established 1995.

EMAME 2007

WAME 2008

 

 

 

FOUNDER;

- Libyan Study group on HIV and Hepatitis

- Libyan Journal of Medicine 2006

- Libyan Society of Hospital Infection 2008

- Libyan Laboratory Society  2010 

 

WEBSITES;

 

www.dmi.ly;                          The First Libyan Acadmic Website ; 2003

www.ljm.org.ly;                     Libyan Journal of Medicine 2006

www.hepatitis.ly                    Libyan Study group of hepatitis 2012

https://scholar.google.com.ly/citations?user=70WDUrEAAAAJ&hl=en&oi=sra

https://www.researchgate.net/profile/Mohamed_Daw2

 

 

WHO- Africa & Mediterranean Regions

 

External Activities

1.     National Professional experience

Date from - Date to

Location

Company

Position

Description

2000-2006

Tripol-Libya

Secratory of Health

Adviser on HIV prevention Program

-National Guide lines , advisory programs, education and preventive programs oh HIV

2003- 2005

Tripoli-Libya

National Centre for preventive Diseases

Director of  National Sero-Epidemiological Studies  on HIV & Viral Hepatitis

Design, Planning the study in terms of objectives  and questionnaires collecting the samples  and data , analysing the results and  writing up the reports & publishing the data

2001-2004

Tripoli-Libya

Tripoli- Central Hospital

Consultant at HIV and Hepatology Unit, Department of Infectious Diseases,                 TCH, Tripoli,

Clinical consultation , in terms of treating and counselling the patients

2000-2004

Tripoli-Libya

Secratory of Health

Consultant at Blood bank services

- Supervising the blood bank services, Quality  Control Assurance

1997-2008

Tripoli-Libya

Secratory of Health

Consultant for Secretary of Health on HIV and Blood bank Services

 Introducing the National  guide lines  on the blood bank service and Planning to over come the HIV crises  and training programs

2005-2008

Tripoli-Libya

Secratory of Health

Consultant on sterilization and Hospital Infection Control

National Guide Line of Hospital Infection Control, Establishement of Hospital Infection Control committee, Training Hospital Staff

1993-1997

Tripol-Libya

National Refernce Laboratory

Laboratory --Director & Chief of central Reference Laboratory in Libya (established 1910)

 

 

- Establishment of National Guide Line on laboratory services, Training  , Quality Control, Bio-safety,  Supervising the  performance of other Laboratories

November 2001-till now, 

Tripoli-Libya

Department of Medical Microbiology, Faculty of Medicine

Professor & Consultant

-Professor & Head of Department of Medical Microbiology, Virology, Immunology

-Consultant Clinical Microbiologist, Central Hospital , Tripoli

 

-Acting Physician at department of Infectious Diseases

 

- Hepatology and HIV clinic; Consultant at TCH

 

Duties included:

 

-The scientific and administrative responsibility of the Department

-Organizing and participating in the teaching program of medical students.

-First established & Responsible for the Msc & PhD programs of post-graduate students in Medical Microbiology.

-Head of the examination committee,

- Consultant physician for HIV & Hepatitis at Tripoli Central Hospital

 

December 2000-November ‏2001‏

Tripoli-Libya

Department of Medical Microbiology, Faculty of Medicine

Professor of Medical Microbiology & Consultant

-Professor of Medical Microbiology

-Consultant Clinical Microbiologist, Blood bank  , Tripoli-

-Acting physician at Department of Medicine and Infectious Diseases

 

 

December 1997- December 2000

Trioli-Libya

Department of Medical Microbiology, Faculty of Medicine

Associate Professor & Consultant

Associate Professor of Medical Microbiology, Faculty of Medicine, Tripoli, Libya

- Consultant Clinical Microbiologist, Central Hospital , Tripoli

 

December 1993 – 1997

Tripoli-Libya

Department of Medical Microbiology, Faculty of Medicine

Assistant Professor & Head of Department & Consultant

-Assistant professor and Head of Department, Department of Medical Microbiology, Faculty of Medicine, Tripoli, Libya

-Director & Chief of central Reference Laboratory in Libya (established 1910)

- Consultant Clinical Microbiologist, Central Hospital , Tripoli

 

August 1992 – December 1993

Tripoli-Libya

Department of Medical Microbiology, Faculty of Medicine

Assistant Professor of Medical Microbiology & Consultant

- Assistant professor at the Department of Medical Microbiology, Faculty of Medicine,  The largest and one of the first medical schools in the country.Tripoli, Libya

- Consultant Clinical Microbiologist, Central Hospital , Tripoli

 

October 1989 – July 1992

Dublin-Ireland,

 

Department of Clinical Microbiology and serology, St James's Hospital Dublin-8

Post-doctorate Fellow ship

- Post-graduate fellowship in Clinical Gastroenterology & Clinical microbiology, Department of Clinical Microbiology and Geastroenterology, University of Dublin, Trinity College, Dublin, IRELAND Duties included:-Working with duodenal ulcer patients and Helicobacter (Campylobacter) Pylori,   Department of Gastroenterology, Meath/Adelaide hospitals Dublin (Prof. Colm O’Morain’s Unit, a member in the European Group Studying H.pylori) -Studies on phospholytic and cytotoxic activity of the organism and its relation to the clinical picture.-Follow-up to infection complication in Hematology-Oncology patients.-Advisor to post-graduate students in Clinical Microbiology and Biochemistry, St. James’s Hospital, Dublin, IRELAND.Clinical seminars.Attended first term of a course for higher diploma in statistics, Trinity College, Dublin, IRELAND- Course in Computer Sciences (Uses and Application)

ctober 1986 – September 1989

Dublin-Ireland

St. James’s Hospital, Dublin

Ph D

Post-graduate studies for Ph.D. in Clinical Microbiology, Department of Clinical Microbiology, St. James’s Hospital, Dublin, IRELAND.The work Included:-Studying the predisposing factors to infection in Haematology – oncology patients.-Surveillance for infection and studying the Epidemiology of Gram-negative bacilli in the unit.-Detailed studies on Antimicrobial therapy, pathogenicity and virulence factors of these organisms. Electron microscopy studies on the adhesions and cellular products of these organisms. Ph.D. Thesis: “Epidemiology of Gram-negative bacilli in neutropenic patients with particular reference to Enterobacter cloacae”.-Demonstrator and tutor in Medical Microbiology, Faculty of Medicine& Health Sciences, Trinity College, Dublin, IRELAND

October 1985 – September 1986

Dublin-Ireland

St James's Hospital Trinity College Dublin

Training Microbiologist

-Foundation Course in Clinical Microbiology, Department of Clinical Microbiology, Central Pathology Laboratory, St. James’s Hospital, Dublin, IRELAND.Training Included:Rotation to all unitsA in the  laboratories of:Media department, Central nerves system specimens, Urology Specimens, Geastroenterology Specimens, Throat and sputum specimens, Mixed Specimens (unclassified sites), Sexually transmitted diseases specimens, Serology, Blood culture and chemotherapy, Tissue culture, Tuberculosis and Anaerobic microbiology.

 

May 1983 – September 1985

Tripoli-Libya

Department of Medical Microbiology Faculty of Medicine, University of Tripoli

Demonstrator in Medical Microbiology,

 

 

Activities Included:

-Teaching third year medical students.

-Diagnostic work and Microbiology consultation in teaching hospitals.

-Microbiology tutor to secondary technical institute trainees.

-Research on whooping cough, Bordetella Pertussis and Sexually Transmitted Diseases.

 

August 1982 – May 1983

Tripoli-Libya

Central Laboratories

Trainee Microbiologist

Microbiology Tutor, Laboratories Diploma Students,

Technical Secondary Institute, Tripoli.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

The Geneva Press Club - Club suisse de la Presse, has the pleasure to invite the international, the Swiss press and its members to a press conference on the theme

“The case of six foreign health workers facing the death penalty in Libya”

With

Professor Mohammed Daw Head of National Committee of Viruses (Below the second part of the press conference - English and Arabic translated to French Q&A session / ci-dessous la deuxième partie de la conférence avec les questions et réponses)